NSE filing, NSE: BLUSPRING. Summary written from the filing by ALFA Finder's alert engine.
Bluspring Enterprises Ltd: key numbers
- Share price
- ₹152.15
- Market cap
- ₹2,275 Cr
- Revenue (annual)
- ₹3,382 Cr
- Net profit (annual)
- ₹-15.34 Cr
- P/E (TTM)
- -205.7×Sector 43.1×
- Promoter holding
- 58.41%+0.36% QoQ
- FII holding
- 5.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bluspring Enterprises Ltd
All →Bluspring Enterprises Board Meeting Date
Bluspring Enterprises has scheduled a board meeting for November 6, 2026, to consider Q2/H1 FY27 unaudited financial results. The trading window stays closed until November 9, 2026.
Bluspring Enterprises Price Movement Clarification
Bluspring Enterprises Limited clarified that there is no material information or impending announcement causing the recent increase in its share trading volume. The movement is market-driven.
Bluspring Enterprises Other Announcement
Bluspring Enterprises Limited has filed the compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Bluspring Enterprises Merger & Restructuring
Bluspring Enterprises approved the amalgamation of its wholly owned subsidiary, Bluspring New Horizon Two, with its wholly owned step-down subsidiary, LSG Sky Chefs India.
Bluspring Enterprises Management Change
Bluspring Enterprises announced the resignation of Company Secretary Arjun Sunil Makhecha and the appointment of Raman Sapra as the new Company Secretary and Compliance Officer.
Bluspring Enterprises Credit Rating
India Ratings assigned a credit rating of IND A/Stable/IND A1 to the bank loan facilities of Bluspring Enterprises' material subsidiary, Vedang Cellular Services.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.